| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.19 | 0.02 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.02 |